The Potential of TRPA1 as a Therapeutic Target in Cancer—A Study Using Bioinformatic Tools
2024
The Potential of TRPA1 as a Therapeutic Target in Cancer
Sample size: 9632
publication
Evidence: moderate
Author Information
Author(s): Cucu Dana
Primary Institution: University of Bucharest
Hypothesis
How does TRPA1 expression correlate with cancer stages, metastases, and immune cell infiltration?
Conclusion
TRPA1 expression is linked to cancer prognosis and may serve as a therapeutic target in various cancers.
Supporting Evidence
- TRPA1 gene is hypermethylated in many cancers.
- High TRPA1 expression correlates with better prognosis in several cancer types.
- TRPA1 expression is linked to immune cell infiltration.
Takeaway
TRPA1 is a gene that can help doctors understand how cancer grows and spreads, and it might be a good target for new treatments.
Methodology
Bioinformatic analysis using databases and public resources to investigate TRPA1 expression and survival analysis.
Limitations
The study lacks animal experiments to verify functional assumptions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website